87 related articles for article (PubMed ID: 19544526)
21. BLCAP induces apoptosis in human Ewing's sarcoma cells.
Fan DG; Zhao F; Ding Y; Wu MM; Fan QY; Shimizu K; Dohjima T; Nozawa S; Wakahara K; Ohno T; Guo YS; Ma BA; Jiang JL
Exp Biol Med (Maywood); 2011 Sep; 236(9):1030-5. PubMed ID: 21844121
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody.
Traini S; Piccolo E; Tinari N; Rossi C; La Sorda R; Spinella F; Bagnato A; Lattanzio R; D'Egidio M; Di Risio A; Tomao F; Grassadonia A; Piantelli M; Natoli C; Iacobelli S
Mol Cancer Ther; 2014 Apr; 13(4):916-25. PubMed ID: 24552775
[TBL] [Abstract][Full Text] [Related]
23. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
[TBL] [Abstract][Full Text] [Related]
24. Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway.
Krishnan K; Bruce B; Hewitt S; Thomas D; Khanna C; Helman LJ
Clin Exp Metastasis; 2006; 23(3-4):227-36. PubMed ID: 17028919
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's sarcoma family of tumors.
López-Guerrero JA; Machado I; Scotlandi K; Noguera R; Pellín A; Navarro S; Serra M; Calabuig-Fariñas S; Picci P; Llombart-Bosch A
Int J Cancer; 2011 Mar; 128(5):1139-50. PubMed ID: 20473914
[TBL] [Abstract][Full Text] [Related]
26. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
Peng W; Huang X; Yang D
Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
[TBL] [Abstract][Full Text] [Related]
27. EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins.
Potikyan G; Savene RO; Gaulden JM; France KA; Zhou Z; Kleinerman ES; Lessnick SL; Denny CT
Cancer Res; 2007 Jul; 67(14):6675-84. PubMed ID: 17638877
[TBL] [Abstract][Full Text] [Related]
28. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
[TBL] [Abstract][Full Text] [Related]
29. Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.
White MJ; Roife D; Gomer RH
J Immunol; 2015 Aug; 195(4):1858-67. PubMed ID: 26136428
[TBL] [Abstract][Full Text] [Related]
30. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
[TBL] [Abstract][Full Text] [Related]
31. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
[TBL] [Abstract][Full Text] [Related]
32. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
33. Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome.
Scotlandi K; Remondini D; Castellani G; Manara MC; Nardi F; Cantiani L; Francesconi M; Mercuri M; Caccuri AM; Serra M; Knuutila S; Picci P
J Clin Oncol; 2009 May; 27(13):2209-16. PubMed ID: 19307502
[TBL] [Abstract][Full Text] [Related]
34. Multiple coagulation factor deficiency protein 2 as a crucial component in metastasis of human oral cancer.
Fukamachi M; Kasamatsu A; Endo-Sakamoto Y; Fushimi K; Kasama H; Iyoda M; Minakawa Y; Shiiba M; Tanzawa H; Uzawa K
Exp Cell Res; 2018 Jul; 368(1):119-125. PubMed ID: 29679592
[TBL] [Abstract][Full Text] [Related]
35. EWS/ETS fusions activate telomerase in Ewing's tumors.
Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kyo S; Ohno T; Taira T; Ariga H; Nakajima K; Hatta M; Kobayashi M; Sano H; Kohgo T; Shindoh M
Cancer Res; 2003 Dec; 63(23):8338-44. PubMed ID: 14678994
[TBL] [Abstract][Full Text] [Related]
36. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
[TBL] [Abstract][Full Text] [Related]
37. EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells.
Hu HM; Zielinska-Kwiatkowska A; Munro K; Wilcox J; Wu DY; Yang L; Chansky HA
J Orthop Res; 2008 Jun; 26(6):886-93. PubMed ID: 18271016
[TBL] [Abstract][Full Text] [Related]
38. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
[TBL] [Abstract][Full Text] [Related]
39. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
[TBL] [Abstract][Full Text] [Related]
40. Effect of intraoral mechanical stress application on the expression of a force-responsive prognostic marker associated with system disease progression.
Zhang Y; Kou X; Jiang N; Liu Y; Tay FR; Zhou Y
J Dent; 2017 Feb; 57():57-65. PubMed ID: 27979689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
